|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Herniorrhaphy | |||||
| Postoperative Pain | |||||
| Inguinal Hernia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hernia | |||||
| Hernia, Inguinal | |||||
| Pain, Postoperative | |||||
| 3 | More general conditions related to this trial | ||||
| Hernia, Abdominal | |||||
| Pain | |||||
| Pathologic Processes | |||||
| Pathological Conditions, Anatomical | |||||
| Postoperative Complications | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Bupivacaine Collagen Sponge | |||||
| placebo collagen sponge | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Bupivacaine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anesthetics | |||||
| Anesthetics, Local | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Innocoll Technologies | |||||
| Premier Research Group plc | |||||